Category: Top Story

VisionSys AI Inc. (NASDAQ:VSA) shares plummeted 75% in premarket trading on Wednesday after the brain-machine interaction technology company unveiled a deeply dilutive registered direct offering, sparking investor concerns over significant share dilution. The company said it had entered into securities purchase agreements with institutional investors to sell 9,230,750 American Depositary Shares (ADS), along with warrants…

Cogent Biosciences Inc. (NASDAQ:COGT) shares dropped 2.4% in premarket trading Wednesday after the biotechnology firm priced two public offerings worth a combined $500 million to strengthen its balance sheet and fund ongoing development programs. The company announced it had upsized its equity offering to 9,677,420 shares at $31.00 per share, raising about $300 million, an…

IperionX Limited ADR (NASDAQ:IPX) shares fell 5.6% in premarket trading Wednesday after Spruce Point Capital Management published a short report on the titanium producer, warning of a potential long-term downside of 70% to 95% under certain conditions. The New York-based investment firm raised doubts about IperionX’s commercial prospects and valuation in a report titled “A…

DBV Technologies (NASDAQ:DBVT) shares surged 7.2% in premarket trading on Wednesday after the French biopharmaceutical company announced the completion of the final patient visit in its Phase 3 VITESSE trial evaluating the VIASKIN Peanut patch. The study assesses the efficacy and safety of the VIASKIN Peanut patch in children aged 4 to 7 years with…

BIO-Key International, Inc. (NASDAQ:BKYI) shares jumped 9.7% in premarket trading on Wednesday after the company announced a strategic partnership with Dubai-based cloud and cybersecurity firm VaporVM. The collaboration is designed to expand BIO-Key’s presence across the Middle East and Africa, combining its advanced identity authentication technologies with VaporVM’s strong regional network and market expertise. As…

Alkermes (NASDAQ:ALKS) shares fell 15% after the company released topline results from its Vibrance-2 Phase 2 trial of alixorexton in patients with narcolepsy type 2. Despite demonstrating strong efficacy, the data failed to fully convince investors. The Dublin-based biopharma firm reported that alixorexton met both primary endpoints, showing statistically significant improvements in wakefulness and excessive…

Vista Energy (NYSE:VIST) announced an ambitious new growth strategy targeting a 50% increase in shale oil production by 2030, rising from 130,000 barrels of oil equivalent per day (boe/d) in the second half of 2025 to over 200,000 boe/d by the end of the decade. During its capital markets day, the company outlined plans to…

Amentum (NYSE:AMTM) shares climbed 2% in U.S. premarket trading after the company announced it had won a major contract worth up to $995 million from the U.S. Air Force Air Combat Command to provide Remotely Piloted Aircraft Maintenance Support. The Indefinite Delivery/Indefinite Quantity (IDIQ) contract will run for a five-year ordering period, supporting the modernization…

BioNexus Gene Lab Corp. (NASDAQ:BGLC) shares jumped 10% after the company announced strategic agreements with Fidelion Diagnostics to jointly commercialize VitaGuard, a next-generation liquid biopsy platform for minimal residual disease (MRD) testing across Southeast Asia. Under the definitive agreements, BioNexus will acquire newly issued Fidelion shares representing at least 15% of Fidelion’s fully diluted equity,…

Arcos Dorados Holdings Inc. (NYSE:ARCO) — the world’s largest independent McDonald’s franchisee — reported third-quarter 2025 results that met earnings expectations while delivering solid sales growth, sending its shares up 4.0% in pre-market trading on Wednesday. The company posted adjusted earnings of $0.71 per share, a sharp increase from $0.17 per share in the same…